SCHEDULE: Avoro Capital Discloses 6.5% Stake in MoonLake
Beneficial Ownership Report
Avoro Capital Advisors and Behzad Aghazadeh have disclosed a 6.5% beneficial ownership stake in MoonLake Immunotherapeutics' Class A Ordinary Shares for investment purposes.
Summary
- Avoro Capital Advisors LLC and Behzad Aghazadeh have filed a Schedule 13G, disclosing their beneficial ownership in MoonLake Immunotherapeutics.
- They collectively own 4,150,000 Class A Ordinary Shares, representing 6.5% of the total class.
- The shares are held solely for investment purposes and not to influence or change control of the issuer.
- Avoro Life Sciences Fund LLC has the right to receive dividends or proceeds from the sale of more than 5% of these shares.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership, indicating an investment stake without providing performance or strategic updates.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Increases transparency for shareholders regarding significant institutional ownership.
- Signals potential investor confidence from Avoro Capital Advisors in MoonLake Immunotherapeutics.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event requiring the filing of this statement (crossing the 5% beneficial ownership threshold). |
| 08/14/2025 | Date of filing of the Schedule 13G statement. |
Keywords
MoonLake Immunotherapeutics, Avoro Capital Advisors, Behzad Aghazadeh, Beneficial Ownership, Schedule 13G, Class A Ordinary Shares, Investment Fund, Biotechnology, Immunotherapeutics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.